Watson to Acquire Andrx for US$1.9 B
By Business Review Editor
Pharma Deals Review: Vol 2006 Issue 70 (Table of Contents)
Published: 6 Apr-2006
DOI: 10.3833/pdr.v2006.i70.537 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
Watson Pharmaceuticals entered into a definitive merger agreement to acquire Andrx for approximately US$1...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS